Key result
High RV wasted work in acute HF is linked to ~90% higher mortality or rehospitalization.
Why the study?
The prognostic role of right ventricular global wasted work (RVGWW), a novel index describing inefficient RV energy expenditure, remained undetermined in acute heart failure patients with RV dysfunction assessed by TAPSE.
Does echocardiographic right ventricular global wasted work (RVGWW >77.3 mmHg/%) predict all-cause mortality and heart failure rehospitalization in acute heart failure patients with right ventricular dysfunction (TAPSE ≤17 mm)?
Cohort (n=476)
Does echocardiographic right ventricular global wasted work (RVGWW >77.3 mmHg/%) predict all-cause mortality and heart failure rehospitalization in acute heart failure patients with right ventricular dysfunction (TAPSE ≤17 mm)?
Increased right ventricular global wasted work (>77.3 mmHg/%) independently predicts worse outcomes and provides incremental prognostic value beyond standard clinical, biochemical, and echocardiographic markers in acute heart failure patients with right ventricular dysfunction.
Elevated RVGWW identifies higher event risk in acute HF with RV dysfunction; extends TAPSE stratification but remains hypothesis-generating pending validation.
Background Right-ventricular (RV) dysfunction assessed by TAPSE is a marker of poor prognosis in acute heart failure (HF). However, the role of the novel index of RV global wasted work (GWW) that describes the inefficient RV energy expenditure remains undetermined in such patients. Purpose This study sought to explore the prognostic value of RVGWW in acute HF patients with impaired TAPSE. Methods Consecutive patients admitted for acute HF were prospectively enrolled and RVGWW was assessed within 24 hours before discharge. For patients with RV dysfunction described as TAPSE ≤17 mm, spline curve analysis was performed to identify the optimal prognostic cut-off value of RVGWW. Patients were followed up for the primary endpoint of all-cause mortality and HF rehospitalization. Results Out of 476 patients included in the study (73.4±11.9 years old, 58.6% male), 265 (55.7%) had TAPSE ≤17 mm, and were further divided into 2 groups; those with RVGWW ≤77.3 mmHg/% (n=165) and those with RVGWW >77.3 mmHg/% (n=100) (Picture 1). During a mean follow-up of 12.0±2.5 months, 183 (38.4%) patients reached the primary endpoint. Patients with TAPSE ≤17 mm & RVGWW >77.3 mmHg/% demonstrated the highest percentage of cumulative events (62.0%) compared to patients with TAPSE >17 mm (31.8%) and patients with TAPSE ≤17 mm & RVGWW ≤77.3 mmHg/% (32.7%), with the latter 2 groups sharing similar risk (Log-rank p <0.001) (Picture 2). RVGWW >77.3 mmHg/% was independently associated with the primary endpoint (adjusted HR: 1.90 [95% CI, 1.18–3.08]; p =0.009) and provided incremental prognostic value over clinical, biochemical, and echocardiographic variables, including RV free wall longitudinal strain (Picture 2). Conclusion Increased RVGWW could re-stratify the prognosis of acute HF patients with established RV dysfunction. RVGWW >77.3 mmHg/% had incremental additive value over and above clinical, biochemical and echocardiographic biomarkers for predicting worse outcome at long-term follow-up.Picture 1Picture 2
No takes yet. Share an insight, caveat, or question.
Anastasiou et al. (2026) conducted a cohort in Acute heart failure with right ventricular dysfunction (n=476). Right ventricular global wasted work (RVGWW) >77.3 mmHg/% in TAPSE ≤17 mm vs. RVGWW ≤77.3 mmHg/% in TAPSE ≤17 mm (and TAPSE >17 mm) was evaluated on All-cause mortality and heart failure rehospitalization (adjusted HR 1.90, 95% CI 1.18-3.08, p=0.009). RV global wasted work >77.3 mmHg/% in acute HF with TAPSE ≤17 mm increased all-cause mortality or HF rehospitalization (62.0% vs 32.7%; adjusted HR 1.90; 95% CI 1.18-3.08; P=0.009).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: